Intravascular devices in intensive care units are often associated to complications. The investigators estimate that 23.5% of catheters placed and used in intensive care are subject to at least one complication; the investigators goal is to demonstrate the effectiveness of the new Tegaderm ™ IV Advanced dressings to achieve a decrease of 35% in the number of complications associated with intravascular catheters in intensive care.

randomized controlled trial of 2 intravascular dressings in Intensive care unit

Inclusion Criteria:

• Patients over 18 years with a central venous catheter, an arterial catheter, a hemodialysis catheter, a Swan Ganz catheter or a peripheral catheter inserted in the ICU or within the 24 before their arrival at the ICU in another ICU setting.
• Patients benefiting from the social security protection.

Exclusion Criteria:

• Patients under 18 years of age,
• Patients having known allergy or sensitivity to adhesive dressing materials